Summary
- Current Price
- As of today, APRE price is $1.00, up +10.17% on
- Current Price All-Time High
- APRE price is currently -99.91% below its historical high of $1,062.20 set on
- Market Cap
- APRE current market cap is $11M, up +38.18% over the past 365 days
- PE Ratio
- APRE PE ratio is unknown
- Revenue
- APRE current annual revenue is $285.80K, down -80.98% year-over-year
- Next Earnings
- As of today, the next earnings release for APRE has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Aprea Therapeutics, Inc. |
| Ticker | NASDAQ: APRE |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | aprea.com |
| Employees | 8 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $1.00 | ||
| Price, 1D Change | +10.17% | |
| $11M | ||
| - | ||
| - | ||
| 1.23 | ||
| $286K | ||
| Revenue, 1Y Change | -80.98% | |
| -$1.93 | ||
| EPS, 1Y Change | +18.07% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.93 | ||
| EPS Estimate | N/A | -$0.81 |
| EPS Est. Change | N/A | +58.22% |
| $285.80K | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $1.00 | ||
| Price Target | - | $5.00 |
| Price Tgt. Change | - | +400.00% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$2.39 | -$2.35 | +1.59% | |
| -$1.91 | -$1.93 | -0.88% | |
| -$0.81 | N/A | +58.22% | |
| -$0.66 | N/A | +65.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.34M | $1.50M | +12.25% | |
| $287.67K | $285.80K | -0.65% | |
| - | N/A | - | |
| $1.07M | N/A | +274.85% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -33.33% | ||
| -75.31% | ||
| +38.18% | ||
| -24.22% | ||
| -80.98% | ||
| +100.00% | ||
| +18.07% | ||
| +99.86% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $1.00 | ||
| $1.20 | ||
| SMA 200 vs Price | +20.00% | |
| $0.77 | ||
| SMA 50 vs Price | -22.76% | |
| 1.23 | ||
| $0.10 | ||
| 67.97 | ||
| 157.12% | ||
| 89.67% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $285.80K | ||
| -$1.93 | ||
| $264.00K | ||
| 92.37% | ||
| -$13.23M | ||
| -4,630.44% | ||
| -$12.60M | ||
| -4,408.54% | ||
| -$13.21M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 5.63 | ||
| 5.63 | ||
| - | ||
| 0 | ||
| -28.59 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| 40.09 | ||
| 0.92 | ||
| 0.24 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $12.44M | ||
| $14.60M | ||
| $15.93M | ||
| $15.56M | ||
| $2.76M | ||
| $2.76M | ||
| $0.00 | ||
| $0.00 | ||
| $713.70K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $12.89M | ||
| $13.50M | ||
| $21.70K | ||
| $0.00 | ||
| $21.70K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$12.89M | ||
| $0.00 | ||
| $4.64M | ||
| $0.00 | ||
| -$12.89M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
Screeners with APRE
FAQ
What is the ticker symbol for Aprea Therapeutics, Inc.?
The ticker symbol for Aprea Therapeutics, Inc. is NASDAQ:APRE
Does Aprea Therapeutics, Inc. pay dividends?
No, Aprea Therapeutics, Inc. does not pay dividends
What sector is Aprea Therapeutics, Inc. in?
Aprea Therapeutics, Inc. is in the Healthcare sector
What industry is Aprea Therapeutics, Inc. in?
Aprea Therapeutics, Inc. is in the Biotechnology industry
What country is Aprea Therapeutics, Inc. based in?
Aprea Therapeutics, Inc. is headquartered in United States
When did Aprea Therapeutics, Inc. go public?
Aprea Therapeutics, Inc. initial public offering (IPO) was on October 3, 2019
Is Aprea Therapeutics, Inc. in the S&P 500?
No, Aprea Therapeutics, Inc. is not included in the S&P 500 index
Is Aprea Therapeutics, Inc. in the NASDAQ 100?
No, Aprea Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Aprea Therapeutics, Inc. in the Dow Jones?
No, Aprea Therapeutics, Inc. is not included in the Dow Jones index
When was Aprea Therapeutics, Inc. last earnings report?
Aprea Therapeutics, Inc.'s most recent earnings report was on November 7, 2025
When does Aprea Therapeutics, Inc. report earnings?
The date for Aprea Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- APRE Official Website aprea.com
- APRE Profile on Yahoo Finance finance.yahoo.com/quote/APRE
- APRE Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/apre